- Abbott Laboratories
- Agouron Pharmaceuticals
- American Society for Nuclear Cardiology
- Ampersand Medical Group
- Astellas Pharma Inc.
- Berkeley HeartLab
- bioMérieux
- Carl Zeiss Meditec
- Chiron Corporation
- DNCB Foundation
- Genaissance Pharmaceuticals
- Genicon Sciences Corporation
- Genzyme Corporation
- Gilead Sciences
- Glaukos Corporation
- Guidant
- IDEC Pharmaceuticals
- Kyphon
- Ligand Pharmaceuticals
- Lumenis
- Market Pulse
- Maxim Pharmaceuticals
- Orqis Medical
- New Heart
- NeXstar Pharmaceuticals
- Paradigms
- Parenta Pharmaceuticals
- Roche Molecular Systems
- Synthes, Inc.
- Thoratec Corporation
- Women First HealthCare
With a unique breadth and depth of expertise, we skillfully assist our clients to meet their own business objectives successfully. Be it conducting market intelligence prior to the launch of a novel pharmaceutical, blazing a trail for reimbursement of a laboratory diagnostic test, or analyzing the cost-effectiveness of an innovative medical device, we have the experience and know-how to produce cogent industry results. We are fluent in all four health care industries and our clients only benefit from our diverse capabilities.